ZA200605721B - The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same - Google Patents

The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same

Info

Publication number
ZA200605721B
ZA200605721B ZA200605721A ZA200605721A ZA200605721B ZA 200605721 B ZA200605721 B ZA 200605721B ZA 200605721 A ZA200605721 A ZA 200605721A ZA 200605721 A ZA200605721 A ZA 200605721A ZA 200605721 B ZA200605721 B ZA 200605721B
Authority
ZA
South Africa
Prior art keywords
glucagon
peptide
preparation
same
receptor agonists
Prior art date
Application number
ZA200605721A
Other languages
English (en)
Inventor
Nan Fajun
Wang Wenlong
Wang Mingwei
Zhou Caihong
Original Assignee
Shanghai Inst Materia Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Materia Medica filed Critical Shanghai Inst Materia Medica
Publication of ZA200605721B publication Critical patent/ZA200605721B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
ZA200605721A 2003-12-12 2006-07-11 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same ZA200605721B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2003101093310A CN100453533C (zh) 2003-12-12 2003-12-12 一类胰高血糖样肽－1受体激动剂及其制备方法和用途

Publications (1)

Publication Number Publication Date
ZA200605721B true ZA200605721B (en) 2007-04-25

Family

ID=34661371

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200605721A ZA200605721B (en) 2003-12-12 2006-07-11 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same

Country Status (13)

Country Link
US (1) US7838682B2 (zh)
EP (1) EP1695968A4 (zh)
JP (1) JP4527665B2 (zh)
KR (1) KR100764863B1 (zh)
CN (1) CN100453533C (zh)
AU (1) AU2003296205B2 (zh)
BR (1) BR0318631A (zh)
CA (1) CA2549355A1 (zh)
IL (1) IL176223A0 (zh)
RU (1) RU2342368C2 (zh)
UA (1) UA87122C2 (zh)
WO (1) WO2005056537A1 (zh)
ZA (1) ZA200605721B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1884278A (zh) * 2005-06-24 2006-12-27 中国科学院上海药物研究所 一类胰高血糖样肽－1受体调节剂、制备方法和用途
CN1896069B (zh) * 2005-07-15 2011-10-05 中国科学院上海药物研究所 一类取代噻唑-4酮化合物、制备方法和用途
CN101195613B (zh) * 2006-12-05 2012-08-08 中国科学院上海药物研究所 一类具有取代四元环结构的化合物及其医学用途
CN101195586A (zh) * 2006-12-05 2008-06-11 中国科学院上海药物研究所 一类具有取代环戊烷结构的化合物、制备方法及其医学用途
CN101195585A (zh) * 2006-12-05 2008-06-11 中国科学院上海药物研究所 一类具有取代环己烷结构的化合物、及其制备方法和医学用途
CN101195584A (zh) * 2006-12-05 2008-06-11 中国科学院上海药物研究所 一类具有取代环丙烷结构的化合物、制备方法及其医学用途
CN101195612B (zh) * 2006-12-05 2012-08-08 中国科学院上海药物研究所 一类具有取代环丁烷结构的化合物、及其制备方法和医学用途
CN101274927B (zh) * 2007-03-29 2011-04-27 中国科学院上海药物研究所 一类四元环状化合物的光化学反应制备方法及其用途
US20120264685A1 (en) 2009-10-22 2012-10-18 Rajesh Bahekar Short chain peptidomimetics based orally active glp 1 agonist and glucagon receptor antagonist
ES2610362T3 (es) 2011-01-25 2017-04-27 Viviabiotech, S.L. Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1
US9409006B2 (en) 2011-04-10 2016-08-09 David Hirshberg Fat removal device and obesity treatment
CN113905734A (zh) * 2019-04-02 2022-01-07 延世大学校产学协力团 新化合物及包含其作为活性成分的预防或治疗呼吸系统疾病的组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5811950B2 (ja) * 1976-12-25 1983-03-05 味の素株式会社 ２，４−置換−５−オキサゾロンの製法
US4912221A (en) * 1988-10-27 1990-03-27 Occidental Chemical Corporation Chiral 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and precursors and preparation thereof
JPH0350532A (ja) * 1989-07-19 1991-03-05 Ajinomoto Co Inc 有機非線形光学材料
JPH09244229A (ja) * 1996-03-07 1997-09-19 Toshiba Corp 感光性組成物及びそれを用いたパターン形成方法
JP3050532B2 (ja) * 1997-04-02 2000-06-12 山進工業株式会社 ロール
JP3092583B2 (ja) * 1998-03-23 2000-09-25 日本電気株式会社 有機エレクトロルミネッセンス素子材料およびそれを使用した有機エレクトロルミネッセンス素子
AR037714A1 (es) * 2001-12-06 2004-12-01 Maxia Pharmaceuticals Inc Derivados de tiazolidinona y oxazolidinona 2-sustituidos para la inhibicion de fosfatasas y el tratamiento de cancer

Also Published As

Publication number Publication date
EP1695968A4 (en) 2007-08-22
UA87122C2 (ru) 2009-06-25
AU2003296205A1 (en) 2005-06-29
US7838682B2 (en) 2010-11-23
CN1626521A (zh) 2005-06-15
RU2006124796A (ru) 2008-01-27
JP2007523828A (ja) 2007-08-23
US20070043093A1 (en) 2007-02-22
EP1695968A1 (en) 2006-08-30
BR0318631A (pt) 2006-10-31
CN100453533C (zh) 2009-01-21
KR100764863B1 (ko) 2007-10-09
IL176223A0 (en) 2006-10-05
CA2549355A1 (en) 2005-06-23
AU2003296205B2 (en) 2008-09-25
KR20060097065A (ko) 2006-09-13
JP4527665B2 (ja) 2010-08-18
WO2005056537A1 (fr) 2005-06-23
RU2342368C2 (ru) 2008-12-27

Similar Documents

Publication Publication Date Title
ZA200605721B (en) The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same
AU2003273300A8 (en) Modified glp-1 receptor agonists and their pharmacological methods of use
ZA200706030B (en) GLP-1 agonists, compositions, methods and uses
ZA200409333B (en) 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors.
AU2002366384A8 (en) Insulin and igf-1 receptor agonists and antagonists
IL177513A0 (en) Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
EP1883419A4 (en) GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR PHARMACOLOGICAL USES
ZA200709266B (en) Human GLP-1 mimetibodies, compositions, methods and uses
HK1079518A1 (en) Quinazolinone derivatives and their use as cb agonists
AU2003233780A1 (en) Novel glucagon antagonists/inverse agonists
AU2003236205A1 (en) Glucagon antagonists/inverse agonists
AU2003238597A8 (en) Benzimidazole compounds and their use as estrogen agonists/antagonists
IL196384A0 (en) Corticotropin releasing factor 2 receptor agonists
ZA200710699B (en) Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor
ZA200210316B (en) Composition and its therapeutic use.
PL370221A1 (en) 2-oxazolamines and their use as 5-ht2b receptor antagonists
AU2003210062A1 (en) Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof
GB0305089D0 (en) Composition, use and process
AU2003300122A1 (en) Agonists and antagonists of the human odorant receptor or17-4 and uses thereof
ZA200608999B (en) Human GLP-1 mimetibodies, compositions, methods and uses
GB0229445D0 (en) Process,composition and use
GB2420345B (en) 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use
ZA200404994B (en) Corticotropin releasing factor 2 receptor agonists
SI1465923T1 (sl) Agonisti receptorja 2 faktorja sproščanja kortikotropina
GB0211926D0 (en) Polypeptide agonists and antagonists